Mobile Strategy to Reduce the Risk of Recurrent Preterm Birth
Trial ID or NCT#
Status
Purpose
Preterm births are defined as delivery prior to 37 weeks gestation and account for 35% of infant deaths in the first year of life. Early preterm birth are deliveries prior to 32 weeks gestation and account for more than 70% of neonatal deaths and 36.1% of overall infant mortality. Women who have delivered a preterm infant and who have a short pregnancy interval (time between giving birth and subsequent conception) have an increased risk of preterm birth in subsequent pregnancies. The investigators hope to understand if a mobile health strategy can be used to reduce spontaneous preterm births via improved patient engagement, care coordination, and adherence to recommended care vs a traditional paper-based health strategy.
Official Title
Randomized Controlled Trial Using Mobile Strategy to Reduce the Risk of Recurrent Preterm Birth
Eligibility Criteria
- 1. Individuals with a mobile phone capable of downloading apps from the Apple App Store or Google Play.2. Participants must consent to the study.3. Women whose child is in the neonatal intensive care unit/nursery because the infant was born preterm.4. Women 16-50 years of age5. Women who can read, write and understand English
- Site-specific additional recruitment criteria
- 1. UPMC Children's Hospital of Pittsburgh: Mothers whose babies have been in the neonatal intensive care unit for more than one month.2. UPMC Magee-Womens Hospital: Mothers who have had a preterm baby of \<36 weeks.
- 1. For this initial study, those who do not have a mobile phone will be excluded. (This exclusion will not affect the inclusion of minorities as minorities Internet use via mobile platforms is equal to or greater than whites; hence we are not excluding minorities, based on the PEW Research Center study (PEW Internet Spring Tracking Survey, April 17-May 19, 2013)).2. Women who have not previously had a preterm birth will be excluded as we are trying to reduce the risk of recurrent preterm birth.
Investigator(s)
View on ClinicalTrials.gov